The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

India's drug regulator has issued a critical warning regarding the illegal sale of single-drug artemisinin formulations, ...

BioCryst secures FDA approval for Orladeyo oral pellets, expanding preventive HAE therapy to children ages 2 to under 12.

Patna: The National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, on Friday inked a memorandum of ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent hereditary angioedema attacks in children aged 2 to under 12, the company ...

In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions ( PTE ): Otsuka ...

Generic drugmaker Granules India’s Hyderabad-based pharmaceutical formulation intermediates and finished dosages manufacturing subsidiary Granules Life Sciences (GLS) has received establishment ...

Daybue Stix, a strawberry-flavored trofinetide powder mixable with water-based liquids, gains FDA approval for Rett syndrome treatment.

Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...